How Newly Approved CPX-351 Will Change AML Treatment

Discussion - CPX-351 is beginning to replace traditional 3+7 chemotherapy for secondary or high-risk AML. Learn what you need to know to use it effectively in the clinic.
Source: Clinical Care Options Leukemia - Category: Hematology Source Type: research